pcDNA3.1 SARS-CoV-2 S D614G Citations (4)

Originally described in: Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro JB, Rafique A, Barve A, Sabeti PC, Kyratsous CA, Dudkina NV, Shen K, Luban J Cell. 2020 Sep 15. pii: S0092-8674(20)31229-0. doi: 10.1016/j.cell.2020.09.032. PubMed Journal

---

Articles Citing pcDNA3.1 SARS-CoV-2 S D614G

Articles
Rapid Detection and Inhibition of SARS-CoV-2-Spike Mutation-Mediated Microthrombosis. Satta S, Lai A, Cavallero S, Williamson C, Chen J, Blazquez-Medela AM, Roustaei M, Dillon BJ, Ashammakhi N, Carlo DD, Li Z, Sun R, Hsiai TK. Adv Sci (Weinh). 2021 Dec;8(23):e2103266. doi: 10.1002/advs.202103266. Epub 2021 Oct 23. PubMed
Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity. Du K, Sun L, Luo Z, Cao Y, Sun Q, Zhang K, Faizy A, Piomelli D, Lu X, Shan J, Yang Q. Metabolism. 2022 Jun;131:155181. doi: 10.1016/j.metabol.2022.155181. Epub 2022 Mar 18. PubMed
SARS-CoV-2 Spike Stem Protein Nanoparticles Elicited Broad ADCC and Robust Neutralization against Variants in Mice. Ma Y, Wang Y, Dong C, Gonzalez GX, Zhu W, Kim J, Wei L, Kang SM, Wang BZ. Small. 2022 Jun;18(25):e2200836. doi: 10.1002/smll.202200836. Epub 2022 May 23. PubMed
Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer. Kim J, Jeong J, Lee CM, Lee DW, Kang CK, Choe PG, Kim NJ, Oh MD, Lee CH, Park WB, Lee KH, Im SA. Front Immunol. 2022 Nov 17;13:1028102. doi: 10.3389/fimmu.2022.1028102. eCollection 2022. PubMed

If you have published an article using this material, please email us at to have your article added to this page.